6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
11m ago	Pacific Valley Bancorp Shows Continued Growth in Loans and Deposits and Improved Profitability in the First Quarter of 2026
11m ago	U-BX Technology Ltd. Announces Pricing of $4.55 Million Registered Direct Offering
12m ago	Company’s 3-for-1 Stock Split Cleared by FINRA for OTC Markets Trading
12m ago	L.B. Foster Company to Report First Quarter 2026 Results on May 4, 2026
13m ago	Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape \| DelveInsight

About

Inflarx N.v. (NASDAQ:IFRX) — investor relations, events, news, and company updates on 6ix.

Latest News

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium

InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting

InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones

InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting

Financials

Revenue

$29.33 K

Market Cap

$65.96 M

EPS

-0.79

Community Chat

Ask AI